Halberd Corporation (HALB)

OTCMKTS · Delayed Price · Currency is USD
0.0015
-0.0002 (-11.76%)
Mar 5, 2026, 2:05 PM EST
Market Cap1.23M -37.4%
Revenue (ttm)6.94K
Net Income-1.71M
EPS-0.00
Shares Out747.30M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume115,000
Average Volume276,913
Open0.0016
Previous Close0.0017
Day's Range0.0015 - 0.0016
52-Week Range0.0011 - 0.0030
Beta0.36
RSI46.39
Earnings Daten/a

About Halberd

Halberd Corporation, a biotech company, develops treatments for neurodegenerative diseases. It offers treatments for post traumatic stress disorder/chronic traumatic encephalopathy, Alzheimer’s and Parkinson’s disease, cancer, blood-borne, and cerebrospinal fluid related diseases. The company was incorporated in 2009 and is based in Jackson Center, Pennsylvania. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2009
Employees 3
Stock Exchange OTCMKTS
Ticker Symbol HALB
Full Company Profile

Financial Performance

Financial Statements